0
Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > FCRL5

FCRL5

Brief Information

Name:Fc receptor-like protein 5
Target Synonym:Fc Receptor-Like 5,CD307e Antigen,PRO820,CD307e,Fc Receptor Like 5,FcR-like protein 5,BXMAS1,Fc receptor homolog 5,FcRH5,Immune receptor translocation-associated protein 2,CD_antigen: CD307e,IRTA2,Immunoglobulin Superfamily Receptor Translocation Associated 2 (IRTA2)
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

FC5-H52H3-SPR
 FCRL5 SPR

Human FCRL5 Protein, His Tag (Cat. No. FC5-H52H3) capture on NTA-Series S sensor chip can bind Ipilimumab with an affinity constant of 28.0 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

FC5-H82E3-SPR
 FCRL5 SPR

Biotinylated Human FCRL5 Protein, His,Avitag (Cat. No. FC5-H82E3) capture on NTA-Series S sensor chip can bind Ipilimumab with an affinity constant of 18.5 μM as determined in a SPR assay (Biacore 8K) (QC tested).

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Cevostamab RG-6160; BFCR-4350A; RO-7187797 Phase 2 Clinical Genentech Inc Multiple Myeloma Details
Anti-FcRL5 CAR-T Cell Therapy(Xuzhou Medical University) Phase 2 Clinical Xuzhou Medical University (Xzmu) Multiple Myeloma Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Nachricht schicken